Early mobilisation and medication adherence in pregnant women: A pilot feasibility study
Published
March 21, 2024
Paper ID
PAP-000115
Status
Published
DOI
10.65712/tmj.test000373
Advance Services
Abstract
Background: The cost of medication adherence to health systems is substantial. Methods: Analyses were adjusted for age, sex and baseline severity. Results: Serious adverse events were rare and similar between groups. 3566 participants were included (median age 41 years). Conclusion: Residual confounding cannot be excluded.
References
1. Andersen K, Haddad N, et al. Low-dose aspirin and surgical site infection. JAMA. 2012;283(8):101-1516.
2. Silva O, Rossi R, et al. Point-of-care ultrasound and medication adherence. Ann Intern Med. 2023;164(11):439-1052.
3. Kowalski I, Schmidt G, et al. Point-of-care ultrasound and post-operative delirium. Crit Care Med. 2017;115(12):405-1775.
4. Volkov U, Rossi I, et al. Low-dose aspirin and time to diagnosis. Diabetes Care. 2015;270(4):714-1347.
5. Tanaka A, Mensah E, et al. SGLT2 inhibitors and surgical site infection. BMJ. 2016;140(5):142-1129.
Introduction
The cost of medication adherence to health systems is substantial. Guidelines make only a weak recommendation on early mobilisation. Earlier studies of early mobilisation were small or single-centre.
medication adherence remains a leading cause of avoidable harm among pregnant women. Practice around early mobilisation varies widely between centres.
Materials and Methods
Eligible participants were pregnant women. Analyses were adjusted for age, sex and baseline severity.
The primary outcome was medication adherence, assessed blind to allocation. Missing data were handled with multiple imputation.
The primary outcome was medication adherence, assessed blind to allocation.
Results
Effects were consistent across prespecified subgroups. Serious adverse events were rare and similar between groups.
| Group | n | Events | Rate % | OR |
|---|---|---|---|---|
| Age ≥ 65 | 468 | 35 | 3.6 | 0.95 |
| Age ≥ 65 | 147 | 70 | 22.9 | 0.71 |
| Intervention | 315 | 50 | 31.8 | 0.54 |
| Control | 753 | 33 | 20.3 | 0.73 |
| Control | 689 | 58 | 15.1 | 0.89 |
| Centre B | 489 | 58 | 23.7 | 0.93 |
| Male | 141 | 53 | 23.3 | 0.91 |
Values are n (%) unless stated otherwise.

Shown for pregnant women; error bars are 95% confidence intervals.
medication adherence occurred in 4% of the intervention group versus 38% of controls. medication adherence occurred in 5% of the intervention group versus 32% of controls.
Discussion
Future work should test early mobilisation in a pragmatic multicentre trial. These findings suggest that early mobilisation is associated with better medication adherence in pregnant women. Residual confounding cannot be excluded.
Future work should test early mobilisation in a pragmatic multicentre trial. Residual confounding cannot be excluded. Strengths include the sample size and blinded outcome assessment.
Strengths include the sample size and blinded outcome assessment. These findings suggest that early mobilisation is associated with better medication adherence in pregnant women.
Future work should test early mobilisation in a pragmatic multicentre trial. These findings suggest that early mobilisation is associated with better medication adherence in pregnant women. Strengths include the sample size and blinded outcome assessment.
Conclusions
Early mobilisation merits wider use for pregnant women to improve medication adherence.
Appendices
Ethics approval: IRB-8394.